CIM INVESTMENT MANAGEMENT INC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 145 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.

Quarter-by-quarter ownership
CIM INVESTMENT MANAGEMENT INC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$203,000
-44.8%
1,721
-92.0%
0.06%
-57.0%
Q1 2019$368,000
+23.9%
21,546
-0.8%
0.14%
+10.1%
Q4 2018$297,000
-52.3%
21,7290.0%0.13%
-41.9%
Q3 2018$622,000
+4.5%
21,7290.0%0.22%
+8.3%
Q2 2018$595,000
+29.9%
21,7290.0%0.20%
+31.4%
Q1 2018$458,00021,7290.16%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders